ADK Stock Overview
Provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
DIAGNOS Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.26 |
| 52 Week High | CA$0.57 |
| 52 Week Low | CA$0.23 |
| Beta | -0.46 |
| 11 Month Change | -26.09% |
| 3 Month Change | -20.31% |
| 1 Year Change | -36.25% |
| 33 Year Change | -38.55% |
| 5 Year Change | 96.15% |
| Change since IPO | -99.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| ADK | CA Healthcare Services | CA Market | |
|---|---|---|---|
| 7D | -12.1% | 0.2% | 0.7% |
| 1Y | -36.3% | 97.0% | 21.7% |
Return vs Industry: ADK underperformed the Canadian Healthcare Services industry which returned 98.2% over the past year.
Return vs Market: ADK underperformed the Canadian Market which returned 21.4% over the past year.
Price Volatility
| ADK volatility | |
|---|---|
| ADK Average Weekly Movement | 9.7% |
| Healthcare Services Industry Average Movement | 8.1% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.6% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: ADK has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: ADK's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | n/a | Andre Larente | www.diagnos.ca |
DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.
DIAGNOS Inc. Fundamentals Summary
| ADK fundamental statistics | |
|---|---|
| Market cap | CA$25.21m |
| Earnings (TTM) | -CA$3.09m |
| Revenue (TTM) | CA$163.53k |
148.4x
P/S Ratio-7.9x
P/E RatioIs ADK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ADK income statement (TTM) | |
|---|---|
| Revenue | CA$163.53k |
| Cost of Revenue | CA$917.33k |
| Gross Profit | -CA$753.81k |
| Other Expenses | CA$2.33m |
| Earnings | -CA$3.09m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.032 |
| Gross Margin | -460.97% |
| Net Profit Margin | -1,886.60% |
| Debt/Equity Ratio | -122.2% |
How did ADK perform over the long term?
See historical performance and comparison